Back
PYXS
PYXIS ONCOLOGY, INC.
🇺🇸 NYSE/NASDAQ
👑 Overview
📈 Performance
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
-24.15%
Annual Growth
4 years average annual capital growth
🌏
5
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Pyxis Oncology, Inc. is a clinical-stage company focused on developing therapeutics to target difficult-to-treat cancers. The Company is building therapeutics that hold the potential for mono and combination therapies. Its clinical program portfolio includes micvotobart pelidotin (MICVO), PYX-106, Sotigalimab (PYX-107), PYX-203, PYX-102, and APX601. The Company’s lead product candidate, MICVO, is an antibody-drug conjugate (ADC) that targets Extradomain-B Fibronectin (EDB+FN), a non-cellular structural component of the tumor extra-cellular matrix (ECM). MICVO is designed to generate a multi-pronged attack on difficult-to-treat cancers by directly killing cancer cells, reducing ECM density, inhibiting tumor angiogenesis and mobilizing an anti-tumor immune response. The Company’s ADC, MICVO, consists of human Immunoglobulin G1 (IgG1) and is site-specifically conjugated with a cleavable linker and a microtubule inhibitor (optimized auristatin) payload.
📈 Performance
Price History*
-91.45%
1M
1Y
All Time
Graph
Table
* US price history does not take into account stock splits
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$1.13
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in PYXS
5
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
80 weeks
💵 Average investment amount
$351
⏰ Last time a customer invested in PYXS
41 days
PYXS investor breakdown
💵 Income of investors
More than 200k
150k - 200k
17%
100k - 150k
50%
50k - 100k
17%
Less than 50k
17%
👶 Age of investors
18 - 25
26 - 34
40%
35 - 90
60%
🙋 Legal gender of investors
Female
60%
Male
40%
Pearlers who invest in PYXS also invest in...
🙌 Performance (5Yr p.a)
18.72%
📊 Share price
$576.92 USD
📈 HIGH PRICE GROWTH
🙌 Performance (5Yr p.a)
308.06%
📊 Share price
$172.41 USD
📈 HIGH PRICE GROWTH
Want more shares? Try these...
🙌 Performance (5Yr p.a)
-3.65%
📊 Share price
